The Long Road to Access – Psychedelics as Medicines
It’s a long and bumpy road ahead before we see psychedelics as medicines generally accepted. Here is my take on the recently presented pyramid by Tadeausz Hawrot.
Uncategorized
Are Psychedelic Treatments a Bargain or a Burden? Examining the Cost-Effectiveness
As psychedelic treatments move towards FDA approval, what will access and affordability look like? We break down the cost-effectiveness data and challenges ahead in ensuring equitable access.
Innovating Mental Health in the EU Pharma Legislation: Regulatory Pathways for Psychedelic Therapies
A summary of the EU Parliament meeting on psychedelic therapies held on November 6th 2023 co-organised by PsychedelicsEUROPE.
Instructions September Onwards
nothing to see here, move along
Scientific News
This page explains the process we take to digest scientific papers. This process is divided into three parts: selection, basic information, deeper exploration.
Trials Update
This page explains the process we take to digest new psychedelic trials. This process is divided into two parts: selection and adding information. 0. You can login here. 2. Adding Information 2.1 New Trial If you are finished with a trial, you can start again at the start of this sequence. 2.2 Updating Trial Many …